Events & Presentations

Arbutus Biopharma Corporation 2017 Third Quarter Financial Results and Corporate Update

Nov 02,2017 1:15 PM PDT

“Arbutus would like to correct a misspeak by Dr. Symonds in this archived webcast. At 9:21, when Dr. Symonds said “with a maximum individual decline of 12.7 logs”, he meant to say “with a maximum individual decline of 2.7 logs.

Back to previous page